Latest posts tagged with #SCRI on Bluesky
SCRI and SCRI Oncology expert, Dr. Meredith Pelster joined Pharmacy Times to discuss emerging data that could meaningfully change the treatment landscape for pancreatic cancer. Watch below to learn more:
www.pharmacytimes.com/view/atebime...
#PancreaticCancer #SCRI #OncologyResearch
This week! And we can't wait! Thursday at 4:00. Right here #SCRI in beautiful #ygk. #gerionc #cancer #aging
SCRI Oncology Partners Welcome Tennessee State Legislators - Erika Hamilton
@erikahamilton9.bsky.social @scri.com
oncodaily.com/voices/erika...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SCRI
⚡️ #Moderna débute une étude pour le traitement d'un #MyélomeMultiple 🩸
La première dose a été administrée au #SCRI Oncology Partners à #Nashville, dans le #Tennessee, en collaboration avec le Sarah Cannon Research Institute (SCRI).
www.tradingsat.com/moderna-US60...
MorningSun trial shows SC mosunetuzumab is effective & well-tolerated for elderly or CIT-ineligible #DLBCL patients. Featuring SCRI’s Dr. Jeff Sharman:
www.hmpgloballearningnetwork.com/site/onc/new... #ASH25 #InnovationInOncology #SCRI
Congrats to our SCRI team for powering 100 abstracts & 50+ investigator-led presentations across hematologic diseases.
Patients remain at the center of all we do—here’s to driving impact beyond Orlando!
#SCRI
Meet #SCRI experts at #ASH25. Visit booth 1580 and view our full schedule: uberflip.scri.com/i/1541695-me...?
Hematology is evolving fast, and SCRI experts are leading the way. Ahead of #ASH25, explore 5 trends shaping research and collaboration this year.
Read more: www.scri.com/news/sarah-c...
#SCRI #ASH25 #Hematology #Oncology
Dr. Sébastien Talbot, a member of #SCRI, explores how the nervous system might have an important role in treating tumors. Read all about how Dr. Talbot is advancing the field of cancer neuroscience ⬇️ @queensuhealth.bsky.social @queensuresearch.bsky.social
www.queensu.ca/gazette/stor...
![[STO Spotlight] Unedited David Spigel on High Risk by Assay Adjuvant Early Stage NSCLC](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:fptm2gxhu5ik4zs4apgth6kv/bafkreicsbylv46ka24yfmniiewhkcqnrdp3ukjzaijbbr7fcjx43c2whya)
Can a molecular assay call you high risk in #lungcancer ? #DrDavidSpigel is looking to figure that out #RazorGenomics youtu.be/loZ4Zpgy9gI @ascocancer.bsky.social #SCRI #P2PMD #ShortTakesInOncology
SCRI expert Dr. Ben Garmezy shares insights on testicular cancer diagnosis, treatment choices, and patient education in this CURE Today feature.
Read more:
www.curetoday.com/view/stage-1...
#CancerEducation #TesticularCancer #SCRI
We're excited to announce the next speaker in our #SCRI seminar series! Dr. Vuk Stambolic will be presenting here
@sinclaircri.bsky.social in #YGK on Oct 30th. Everyone is welcome! @pmresearch-uhn.bsky.social @queensuhealth.bsky.social @queensuresearch.bsky.social #breastcancer
Your breast cancer risk is personal—and understanding it is powerful.
SCRI's Dr. Denise Yardley shares how genetic testing is changing prevention on @newschannel5plus.bsky.social .
🎥 Watch: bit.ly/DrYardleyBCAM
#BCAM #BreastCancerAwareness #EarlyDetection #SCRI
Sarah Cannon Research Institute - Honoring President and Chief Medical Officer, Dr. Howard “Skip” Burris
@scri.com
oncodaily.com/career/chief...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SCRI
At 45, Bryan was diagnosed with advanced prostate cancer.
A BRCA mutation led him to a clinical trial through SCRI at Texas Oncology.
Today, his PSA levels are undetectable—and he’s thriving. 💙
#ProstateCancer #BRCA #SCRI #TexasOncology #USOncologyNetwork #ClinicalTrials #CancerResearch
Bill, 76, joined a clinical trial at SCRI to treat stage IV prostate cancer. His goal: dance at his daughter’s wedding. ✅
Now celebrating a grandchild & still practicing law—while seeing a 15% reduction in disease.
Hope lives here.
🔗 www.scri.com/patients/?co...
#SCRI #ClinicalTrials #ProstateCancer
🎧 SCRI’s Dr. Garmezy & Dr. Bupathi share expert insights on treating variant histologies in GU cancers at #WorldGU2025 on Oncology Decoded.
🔗 www.cancernetwork.com/view/episode...
#SCRI #CancerResearch #GUOncology #OncologyDecoded
Mary is proof that hope and research go hand in hand.
She’s in a clinical trial for IV #ovariancancer at #SCRI at Mary Crowley—and her disease has remained stable since March.
She’s walked the Camino de Santiago, joined the Lourdes Pilgrimage, & got a tattoo to celebrate it all. #PatientStories
Dr. Hans Lee & Dr. Kris Patel from SCRI Oncology share how new therapies like CAR T-cell treatment are changing lives.
📺 Watch the News Channel 5 segment: www.youtube.com/watch?v=hg4_...
#BloodCancerAwareness #LymphomaAwareness #CancerCare #SCRI
Dr. Jason Henry featured on @DenverChannel discussing early data from a promising #pancreaticcancer vaccine.
“This is one of the most exciting times in pancreatic cancer research in the last 100 years.”
#SCRI #CancerResearch #ClinicalTrials
www.denver7.com/lifestyle/he...
![[STO Spotlight] Unedited Ben Garmezy on two-dose escalation cohorts of Ph 1b STELLAR 002 study](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:fptm2gxhu5ik4zs4apgth6kv/bafkreienbozoi4pex5vn2z3j5hbyti47lmeksuvx5gmtg4zrwrlt2n5wna)
youtube.com/watch?v=PkXEvgjh37Y
Nice presentation by #DrBenGarmezy @ascocancer.bsky.social of his poster! Work still continues to unlock #cancer in solid tumors. #SCRI #Exelixis #shorttakesinoncology
JP was diagnosed with stage IV lung cancer. He joined a clinical trial through SCRII at OHC—and responded to immunotherapy.
Now in remission, he celebrates each year with a cake and a message of hope. 🎂
#SCRI #CancerSurvivor #Immunotherapy #ClinicalResearch
www.scri.com/patients/?co...
New from #CancerNetwork: Dr. Erika Hamilton of SCRI Oncology Partners shares insights on ADCs, CDK4/6 inhibitors & early breast cancer care from #IBC25.
🎧 Listen: www.cancernetwork.com/view/highlig...
#BreastCancer #Oncology #SCRI
💡 Why consider a clinical trial during your cancer journey?
✨ Access cutting-edge treatments
✨ Stay close to home
✨ Help shape the future of cancer care
🎥 Watch our latest video to learn more: www.scri.com/patients/
#CancerAwareness #ClinicalTrials #OncologyResearch #SCRI #HopeCloseToHome
Thank you, #ASCO25!
We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration.
Here’s to advancing therapies for patients —together.
Until next year!
#SCRI #CancerResearch #OncologyLeadership #ThankYouASCO
🚨 LIVE from #ASCO25 🚨
Dr. Erika Hamilton presents first-in-human data on Emi-Le (B7-H4 ADC) in solid tumors.
🔹 ORR: 31% in B7-H4 high
🔹 ORR: 44% w/ ≤4 prior lines
🔹 ACC-I: 55.6% ORR
Promising activity + tolerability in mBC, OC, EC & ACC-I.
#SCRI #ADC #Oncology #ASCO2025
Dr. Johnson tackled how community oncology can deliver cutting-edge lung cancer therapies:
🔹 Not all bispecifics need inpatient care
🔹 Tarlatamab = outpatient-friendly
🔹 Innovative care models = better access
#LungCancer #Immunotherapy #SCRI #ASCO25
🔬 At #ASCO25, Dr. Naqash explored the promise & challenges of bispecific T-cell engagers (BiTEs) in lung cancer & beyond:
✅ Tarlatamab earns FDA nod for SCLC
⚠️ CRS & ICANS toxicity management is key
🎯 DLL3 & other targets may expand BiTE reach
#Immunotherapy #LungCancer #SCRI
